Title Heterogeneity of cardiac sympathetic nerve activity and systolicdysfunction in patients with hypertrophic cardiomyopathy

*KURAに登録されているコンテンツの利用については,著作権法に規定されている私的使用や引用などの範囲内で行ってください。 *著作権法に規定されている私的使用や引用などの範囲を超える利用を行う場合には,著作権者の許諾を得てください。ただし,著作権者 から著作権等管理事業者(学術著作権協会,日本著作出版権管理システムなど)に権利委託されているコンテンツの利用手続については ,各著作権等管理事業者に確認してください。 Title Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy Author(s) Shimizu, Masami; Ino, Hidekazu; Yamaguchi, Masato; Terai, Hidenobu; Hayashi, Kenshi; Nakajima, Kenichi; Taki, Junichi; Mabuchi, Hiroshi Citation Journal of Nuclear Medicine, 43(1): 15-20

[1]  桶家 一恭.  Left Ventricular Systolic Dysfunction During Exercise and Dobutamine Stress in Patients With Hypertrophic Cardiomyopathy , 2001 .

[2]  D. Goldstein,et al.  Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. , 2000, Journal of the American College of Cardiology.

[3]  H. Watkins,et al.  Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. , 1999, Cardiovascular research.

[4]  H. Kasanuki,et al.  Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy. , 1999, Nuclear medicine communications.

[5]  P. Merlet,et al.  Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. , 1999, Journal of the American College of Cardiology.

[6]  B. Hainque,et al.  Familial hypertrophic cardiomyopathy: from mutations to functional defects. , 1998, Circulation research.

[7]  S. Ziegler,et al.  Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. , 1998, Circulation.

[8]  M. Uusitupa,et al.  Noninvasive Detection of Cardiac Sympathetic Nervous Dysfunction in Diabetic Patients Using [123I]Metaiodobenzylguanidine , 1992, Diabetes.

[9]  E. Botvinick,et al.  Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts--implications for clinical studies. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  P. Merlet,et al.  Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  K. Nakajima,et al.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy. , 1992, British heart journal.

[12]  M. Shimizu,et al.  An autopsy case of hypertrophic cardiomyopathy showing dilated cardiomyopathy-like features by serial ventriculography. , 1990, Japanese journal of medicine.

[13]  K. Nakajima,et al.  Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. , 1990, American heart journal.

[14]  R. Popp,et al.  Ultrasonic tissue characterization of human hypertrophied hearts in vivo with cardiac cycle-dependent variation in integrated backscatter. , 1989, Circulation.

[15]  B. Maron,et al.  Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. , 1989, Circulation.

[16]  J. Roelandt,et al.  Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy. , 1979, American heart journal.

[17]  B. Maron,et al.  Hypertrophic cardiomyopathy: a discussion of nomenclature. , 1979, The American journal of cardiology.